Abstract: The invention provides compounds of the formula I
wherein the substitutents are as described herein.
Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia, and also provided are pharmaceutical compositions containing such compounds.
Type:
Grant
Filed:
July 31, 2002
Date of Patent:
December 30, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
Chongqing Sun, Jeffrey A. Robl, Mark E. Salvati, Tammy Wang, Lawrence Hamann, David Augeri